{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:07:55Z","timestamp":1769605675760,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR042334"],"award-info":[{"award-number":["AR042334"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005885","name":"Shimabara Science Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jid.2018.11.016","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T11:48:36Z","timestamp":1543578516000},"page":"1150-1160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy"],"prefix":"10.1016","volume":"139","author":[{"given":"Takashi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Saigusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.11.016_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.39062","article-title":"Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability","volume":"67","author":"Akamata","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01972825","article-title":"Effects of dazmegrel, piroxicam and cyclophosphamide on the NZB\/W model of SLE","volume":"27","author":"Archer","year":"1989","journal-title":"Agents Actions"},{"key":"10.1016\/j.jid.2018.11.016_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2018.11.016_bib4","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2018.11.016_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/ten.teb.2009.0630","article-title":"Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering","volume":"16","author":"Beamish","year":"2010","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jid.2018.11.016_bib6","first-page":"733","article-title":"Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis","volume":"22","author":"Beon","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib7","doi-asserted-by":"crossref","first-page":"e0130166","DOI":"10.1371\/journal.pone.0130166","article-title":"Systemic sclerosis sera impair angiogenic performance of dermal microvascular endothelial cells: therapeutic implications of cyclophosphamide","volume":"10","author":"Borghini","year":"2015","journal-title":"PLoS One"},{"issue":"2 Pt 1","key":"10.1016\/j.jid.2018.11.016_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1078-0432.CCR-06-1209","article-title":"Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration","volume":"13","author":"Bracci","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.11.016_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10067-008-1058-y","article-title":"Cyclophosphamide treatment improves microvessel damage in systemic sclerosis","volume":"28","author":"Caramaschi","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0896-8411(90)90143-G","article-title":"Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization","volume":"3","author":"Caspi","year":"1990","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2018.11.016_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1573397111309020005","article-title":"Pathogenesis and therapeutics of interstitial lung disease in systemic sclerosis","volume":"9","author":"Castillo-Tandazo","year":"2013","journal-title":"Curr Rheumatol Rev"},{"issue":"suppl 92","key":"10.1016\/j.jid.2018.11.016_bib12","first-page":"S3","article-title":"Systemic sclerosis: from pathogenesis to targeted therapy","volume":"33","author":"Denton","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib13","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/rheumatology\/keq259","article-title":"Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis","volume":"49","author":"Furuya","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2018.11.016_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood-2006-07-036202","article-title":"The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration","volume":"110","author":"Grote","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.11.016_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2018.11.016_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01965044","article-title":"Effects of immunomodulating treatment on autoimmune sialadenitis in MRL\/Mp-lpr\/lpr mice","volume":"25","author":"Jonsson","year":"1988","journal-title":"Agents Actions"},{"key":"10.1016\/j.jid.2018.11.016_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2018.11.016_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen\u00a0transcription, in fibrotic scleroderma skin","volume":"163","author":"Kubo","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2018.11.016_bib19","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/art.38326","article-title":"Impaired in\u00a0vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis","volume":"66","author":"Kuwana","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"9434","key":"10.1016\/j.jid.2018.11.016_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.11.016_bib21","first-page":"255","article-title":"Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative","volume":"73","author":"Limpens","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2018.11.016_bib22","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.11.016_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/s10165-012-0660-7","article-title":"Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis","volume":"23","author":"Masui","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","article-title":"Anti-endothelial cell antibodies in systemic sclerosis","volume":"69","author":"Mihai","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2018.11.016_bib26","doi-asserted-by":"crossref","first-page":"e32272","DOI":"10.1371\/journal.pone.0032272","article-title":"A\u00a0possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis","volume":"7","author":"Noda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2018.11.016_bib27","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2018.11.016_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2018.11.016_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jid.2018.11.016_bib30","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","article-title":"Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis","volume":"75","author":"Romano","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2018.11.016_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/exd.12602","article-title":"A\u00a0possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis","volume":"24","author":"Saigusa","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2018.11.016_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.14183","article-title":"Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions","volume":"174","author":"Saigusa","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.11.016_bib33","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood.V95.6.2024","article-title":"Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer","volume":"95","author":"Schiavoni","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.11.016_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2018.11.016_bib35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/s10165-012-0755-1","article-title":"Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis","volume":"23","author":"Takahashi","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/s10165-011-0545-1","article-title":"Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases","volume":"22","author":"Takahashi","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib37","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.14699","article-title":"A\u00a0potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis","volume":"175","author":"Takahashi","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.11.016_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.13779","article-title":"A\u00a0possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis","volume":"173","author":"Takahashi","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.11.016_bib39","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2018.11.016_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/1346-8138.13553","article-title":"Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis","volume":"44","author":"Takahashi","year":"2017","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2018.11.016_bib41","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3899\/jrheum.161092","article-title":"Fli1 deficiency induces CXCL6 expression in dermal fibroblasts and endothelial cells, contributing to the development of fibrosis and vasculopathy in systemic sclerosis","volume":"44","author":"Taniguchi","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2018.11.016_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00403-017-1786-4","article-title":"A\u00a0possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis","volume":"309","author":"Taniguchi","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2018.11.016_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1242\/dev.002071","article-title":"FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages","volume":"135","author":"Tigges","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.jid.2018.11.016_bib44","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/exd.13341","article-title":"The impact of transcriptional factor Fli1 deficiency on the regulation of angiogenesis","volume":"26","author":"Toyama","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2018.11.016_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2018.11.016_bib46","doi-asserted-by":"crossref","first-page":"e1356152","DOI":"10.1080\/2162402X.2017.1356152","article-title":"Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF\/ATG induced GVHD protective activity and improve haploidentical transplant outcomes","volume":"6","author":"Wang","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2018.11.016_bib47","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.11.016_bib48","article-title":"Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis","author":"Yamashita","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2018.11.016_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/exd.12920","article-title":"A\u00a0potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis","volume":"25","author":"Yamashita","year":"2016","journal-title":"Exp Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18329026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18329026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:12:12Z","timestamp":1758301932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18329026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0022202X18329026"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.11.016","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}